CRO Site Feasibility and Protocol Alignment Matrix

Role: Director of Clinical Proposals and Feasibility at a global contract research organization.

Context

• Sponsor biopharma organization: {{sponsor_biotech}}
• Target therapeutic indication: {{therapeutic_area}}
• Clinical development stage: {{trial_phase}}
• Protocol operational drivers: {{protocol_complexity_drivers}}
• Target recruitment geographies: {{geographical_regions}}
• Commercial budget allocation: {{budget_envelope}}

Task

Construct a site feasibility and protocol alignment proposal matrix that demonstrates operational execution viability, patient recruitment timelines, and cost control for {{sponsor_biotech}}.

Method

1. Analyze {{protocol_complexity_drivers}} within the context of {{therapeutic_area}} clinical endpoints.
2. Map investigator site availability across {{geographical_regions}} for the target {{trial_phase}} population.
3. Calculate patient enrollment velocity curves based on historical site network performance.
4. Identify regulatory bottleneck risks and ethics committee review timelines across each region.
5. Align CRO operational resourcing models to the financial constraints of {{budget_envelope}}.
6. Formulate value-added differentiators such as decentralized trial components or proprietary biomarker assay partnerships.
7. Synthesize site activation milestones into a comparative operational risk matrix.

Constraints

• MUST output the core evaluation as a comparative feasibility matrix detailing geographic operational parameters.
• MUST NOT propose recruitment schedules that deviate from verified historical site activation benchmarks.
• Focus exclusively on the requirements outlined for {{sponsor_biotech}}'s trial protocol.
• Exclude generic CRO marketing boilerplate; deliver empirical feasibility metrics.

Output format

1. Proposal Baseline Overview (1 paragraph, max 80 words).
2. Protocol Operational Feasibility Matrix (Markdown table with columns: Geographical Region, Planned Site Count, Patient Target, Regulatory Approval Timeline, Operational Risk Tier, Mitigation Strategy).
3. Commercial Milestone Summary (4 bullet points detailing delivery milestones within {{budget_envelope}}).

Self-review

• Check 1: Does the matrix address all territories specified in {{geographical_regions}}?
• Check 2: Are the operational timelines aligned with {{trial_phase}} standards for {{therapeutic_area}}?
• Check 3: Is the milestone summary fully consistent with {{budget_envelope}}?